Patent application number | Description | Published |
20100075308 | POLYMORPHISMS IN GENES AFFECTING CNS DISORDERS AND USES THEREOF - Diagnostic and prognostic methods, compositions, assays, and kits useful for predicting the phenotype of subjects who have, or are at risk of developing, a mental disorder. The methods also include predicting the prognostic outcome of a subject's mental disorder as well as the subject's responsiveness to drug treatments for the mental disorder. The methods and kits include determining the allelic status of polymorphisms in the MAOA, TPH2 and DRD2 genes. | 03-25-2010 |
20100129818 | Polymorphisms in Genes Affecting CYP2C9-Related Disorders and Uses Thereof - A method for predicting a subject's risk factors for CYP2C9-related disorders includes detecting the allelic status of one or more polymorphisms in a nucleic acid sample of the subject. | 05-27-2010 |
20100143921 | Polymorphisms in Genes Affecting Dopamine Transporter Disorders and Uses Thereof - A method for predicting a subject's risk factors for dopamine transporter or SLC6A3-related disorders. The method includes detecting the allelic status of one or more polymorphisms in a nucleic acid sample of the subject. The present invention also provides a related kit, comprising an assay for detecting the allelic status of one or more polymorphisms in a nucleic acid sample of a subject. | 06-10-2010 |
20100167947 | Polymorphisms in Genes Affecting Ace-Related Disorders and Uses Thereof - A method for predicting a subject's risk factors for ACE-related disorders includes detecting the allelic status of one or more polymorphisms in a nucleic acid sample of the subject. | 07-01-2010 |
20120040347 | Polymorphism in CYP3A4 Gene Affecting Drug Metabolizing and Uses Thereof - A method for predicting a subject's risk factors for CYP3A4-related disorders includes detecting the allelic status of a SNP in a nucleic acid sample of the subject. | 02-16-2012 |
20140044668 | Methods for Predicting Cardiovascular Risks and Responsiveness to Statin Therapy Using SNPs - Methods and compositions for the effect of Cholesteryl ester transfer protein (CETP) polymorphisms on mRNA splicing, statin treatment outcome, response to CETP inhibitor drugs, and myocardial infarction risk are described. | 02-13-2014 |
20140255930 | Materials and Methods Related to Dopamine Dysregulation Disorders - The present invention provides methods of identifying an increased risk of a dopamine dysregulation disorder in a human subject, including identifying increased risk of dementia, Parkinson's disease, Huntington's, epilepsy, mania, attention deficit disorder, anxiety, dyslexia, schizophrenia, depression, obsessive-compulsive disorders, alcoholism, obesity, addiction disorders, pathological gambling, attention deficit hyperactivity disorder, bipolar disorder, Tourette syndrome, substance dependence, sub stance abuse, substance overdose, and substance-related death. | 09-11-2014 |